Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Hormone levels studied are not linked to PCOS.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Women with androgenetic alopecia have lower SHBG levels.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Lowering certain hormone levels improves treatment for hair loss in young men.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Hair analysis shows low progesterone in anorexia patients, unchanged by short-term weight gain.

PCOS is linked to hormone disorders and issues like infertility and irregular periods.

Sex hormones do not cause oral lichen planus.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Alopecia areata patients have higher hormone levels, suggesting hormonal screening could help in treatment.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The CRH/CRH-R1 system might be involved in causing lichen planus.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride with lifestyle changes effectively treats acne in males by improving hormone levels and reducing recurrence.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.